Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 157

1.

Immune regulation of metastasis: mechanistic insights and therapeutic opportunities.

Blomberg OS, Spagnuolo L, de Visser KE.

Dis Model Mech. 2018 Oct 24;11(10). pii: dmm036236. doi: 10.1242/dmm.036236. Review.

2.

Diminished Hedonic response in neuroleptic-free youth at ultra high-risk for psychosis.

Strauss GP, Ruiz I, Visser KH, Crespo LP, Dickinson EK.

Schizophr Res Cogn. 2017 Dec 23;12:1-7. doi: 10.1016/j.scog.2017.12.001. eCollection 2018 Jun.

3.

Implementing Non-violent Resistance, a Method to Cope with Aggression in Child and Adolescent Residential Care: Exploration of Staff Members Experiences.

van Gink K, Visser K, Popma A, Vermeiren RRJM, van Domburgh L, van der Stegen B, Jansen LMC.

Arch Psychiatr Nurs. 2018 Jun;32(3):353-359. doi: 10.1016/j.apnu.2017.11.025. Epub 2017 Nov 21.

PMID:
29784214
4.

Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape.

Wellenstein MD, de Visser KE.

Immunity. 2018 Mar 20;48(3):399-416. doi: 10.1016/j.immuni.2018.03.004. Review.

PMID:
29562192
5.

Anhedonia reflects impairment in making relative value judgments between positive and neutral stimuli in schizophrenia.

Strauss GP, Visser KF, Keller WR, Gold JM, Buchanan RW.

Schizophr Res. 2018 Feb 27. pii: S0920-9964(18)30090-2. doi: 10.1016/j.schres.2018.02.016. [Epub ahead of print]

PMID:
29499966
6.

Implicit Cognitions as a Behavioral Marker of Suicide Attempts in Adolescents.

Millner AJ, Augenstein TM, Visser KH, Gallagher K, Vergara GA, D'Angelo EJ, Nock MK.

Arch Suicide Res. 2018 Mar 14:1-17. doi: 10.1080/13811118.2017.1421488. [Epub ahead of print]

PMID:
29482489
7.

Sensitivity of the Positive and Negative Syndrome Scale (PANSS) in Detecting Treatment Effects via Network Analysis.

Esfahlani FZ, Sayama H, Visser KF, Strauss GP.

Innov Clin Neurosci. 2017 Dec 1;14(11-12):59-67.

8.

An ecological momentary assessment evaluation of emotion regulation abnormalities in schizophrenia.

Visser KF, Esfahlani FZ, Sayama H, Strauss GP.

Psychol Med. 2018 Oct;48(14):2337-2345. doi: 10.1017/S0033291717003865. Epub 2018 Jan 24.

PMID:
29361997
9.

The adaptive immune system promotes initiation of prostate carcinogenesis in a human c-Myc transgenic mouse model.

Melis MHM, Nevedomskaya E, van Burgsteden J, Cioni B, van Zeeburg HJT, Song JY, Zevenhoven J, Hawinkels LJAC, de Visser KE, Bergman AM.

Oncotarget. 2017 Sep 28;8(55):93867-93877. doi: 10.18632/oncotarget.21305. eCollection 2017 Nov 7.

10.

Neutrophils take a round-trip.

Garner H, de Visser KE.

Science. 2017 Oct 6;358(6359):42-43. doi: 10.1126/science.aap8361. No abstract available.

PMID:
28983037
11.

Semi-automated camera trap image processing for the detection of ungulate fence crossing events.

Janzen M, Visser K, Visscher D, MacLeod I, Vujnovic D, Vujnovic K.

Environ Monit Assess. 2017 Sep 27;189(10):527. doi: 10.1007/s10661-017-6206-x.

PMID:
28956203
12.

Mammary tumor-derived CCL2 enhances pro-metastatic systemic inflammation through upregulation of IL1β in tumor-associated macrophages.

Kersten K, Coffelt SB, Hoogstraat M, Verstegen NJM, Vrijland K, Ciampricotti M, Doornebal CW, Hau CS, Wellenstein MD, Salvagno C, Doshi P, Lips EH, Wessels LFA, de Visser KE.

Oncoimmunology. 2017 Jun 19;6(8):e1334744. doi: 10.1080/2162402X.2017.1334744. eCollection 2017.

13.

The Determination of Sugars in Dairy Products: Development of a New Standard Method for the International Dairy Federation and the Internal Organization for Standardization.

Sanders P, Ernste-Nota V, Visser K, van Soest J, Brunt K.

J AOAC Int. 2017 Sep 1;100(5):1577-1581. doi: 10.5740/jaoacint.17-0068. Epub 2017 May 11.

PMID:
28492132
14.

A Genetic Population Isolate in The Netherlands Showing Extensive Haplotype Sharing and Long Regions of Homozygosity.

Somers M, Olde Loohuis LM, Aukes MF, Pasaniuc B, de Visser KCL, Kahn RS, Sommer IE, Ophoff RA.

Genes (Basel). 2017 May 4;8(5). pii: E133. doi: 10.3390/genes8050133.

15.

A randomized controlled trial to examine the effects of the Tackling Teenage psychosexual training program for adolescents with autism spectrum disorder.

Visser K, Greaves-Lord K, Tick NT, Verhulst FC, Maras A, van der Vegt EJM.

J Child Psychol Psychiatry. 2017 Jul;58(7):840-850. doi: 10.1111/jcpp.12709. Epub 2017 Mar 9.

PMID:
28276079
16.

Initial development and preliminary psychometric properties of the Prodromal Inventory of Negative Symptoms (PINS).

Pelletier-Baldelli A, Strauss GP, Visser KH, Mittal VA.

Schizophr Res. 2017 Nov;189:43-49. doi: 10.1016/j.schres.2017.01.055. Epub 2017 Feb 8.

17.

Genetically engineered mouse models in oncology research and cancer medicine.

Kersten K, de Visser KE, van Miltenburg MH, Jonkers J.

EMBO Mol Med. 2017 Feb;9(2):137-153. doi: 10.15252/emmm.201606857. Review.

18.
19.

Neutrophils in cancer: neutral no more.

Coffelt SB, Wellenstein MD, de Visser KE.

Nat Rev Cancer. 2016 Jul;16(7):431-46. doi: 10.1038/nrc.2016.52. Epub 2016 Jun 10. Review.

PMID:
27282249
20.

The phytoestrogenic Cyclopia extract, SM6Met, increases median tumor free survival and reduces tumor mass and volume in chemically induced rat mammary gland carcinogenesis.

Visser K, Zierau O, Macejová D, Goerl F, Muders M, Baretton GB, Vollmer G, Louw A.

J Steroid Biochem Mol Biol. 2016 Oct;163:129-35. doi: 10.1016/j.jsbmb.2016.04.019. Epub 2016 Apr 30.

PMID:
27142456
21.

CANCER. How neutrophils promote metastasis.

Tüting T, de Visser KE.

Science. 2016 Apr 8;352(6282):145-6. doi: 10.1126/science.aaf7300. No abstract available.

PMID:
27124439
22.

Revving Up Dendritic Cells while Braking PD-L1 to Jump-Start the Cancer-Immunity Cycle Motor.

Coffelt SB, de Visser KE.

Immunity. 2016 Apr 19;44(4):722-4. doi: 10.1016/j.immuni.2016.03.014.

23.

Systemic inflammation: Cancer's long-distance reach to maximize metastasis.

Coffelt SB, de Visser KE.

Oncoimmunology. 2015 Aug 17;5(2):e1075694. eCollection 2016 Feb.

24.

Autism Spectrum Disorders in Africa: Current Challenges in Identification, Assessment, and Treatment: A Report on the International Child Neurology Association Meeting on ASD in Africa, Ghana, April 3-5, 2014.

Ruparelia K, Abubakar A, Badoe E, Bakare M, Visser K, Chugani DC, Chugani HT, Donald KA, Wilmshurst JM, Shih A, Skuse D, Newton CR.

J Child Neurol. 2016 Jul;31(8):1018-26. doi: 10.1177/0883073816635748. Epub 2016 Mar 15. Review.

PMID:
26979098
25.

Exploiting the Immunomodulatory Properties of Chemotherapeutic Drugs to Improve the Success of Cancer Immunotherapy.

Kersten K, Salvagno C, de Visser KE.

Front Immunol. 2015 Oct 7;6:516. doi: 10.3389/fimmu.2015.00516. eCollection 2015. Review.

26.

Study protocol: a randomized controlled trial investigating the effects of a psychosexual training program for adolescents with autism spectrum disorder.

Visser K, Greaves-Lord K, Tick NT, Verhulst FC, Maras A, van der Vegt EJ.

BMC Psychiatry. 2015 Aug 28;15:207. doi: 10.1186/s12888-015-0586-7.

27.

Divide and Conquer May Not Be the Optimal Approach to Retain the Desirable Estrogenic Attributes of the Cyclopia Nutraceutical Extract, SM6Met.

Mortimer M, Visser K, de Beer D, Joubert E, Louw A.

PLoS One. 2015 Jul 24;10(7):e0132950. doi: 10.1371/journal.pone.0132950. eCollection 2015.

28.

Familial Aggregation between the 14th and 21st Century and Type 2 Diabetes Risk in an Isolated Dutch Population.

de Visser KL, Landman GW, Kleefstra N, Meyboom-de Jong B, de Visser W, te Meerman GJ, Bilo HJ.

PLoS One. 2015 Jul 20;10(7):e0132549. doi: 10.1371/journal.pone.0132549. eCollection 2015. Erratum in: PLoS One. 2015;10(9):e0137939. Kleefstra, Nanne [added].

29.

Linkage analysis in a Dutch population isolate shows no major gene for left-handedness or atypical language lateralization.

Somers M, Ophoff RA, Aukes MF, Cantor RM, Boks MP, Dauwan M, de Visser KL, Kahn RS, Sommer IE.

J Neurosci. 2015 Jun 10;35(23):8730-6. doi: 10.1523/JNEUROSCI.3287-14.2015.

30.

On the relationship between degree of hand-preference and degree of language lateralization.

Somers M, Aukes MF, Ophoff RA, Boks MP, Fleer W, de Visser KC, Kahn RS, Sommer IE.

Brain Lang. 2015 May;144:10-5. doi: 10.1016/j.bandl.2015.03.006. Epub 2015 Apr 13.

PMID:
25880901
31.

Immune-mediated mechanisms influencing the efficacy of anticancer therapies.

Coffelt SB, de Visser KE.

Trends Immunol. 2015 Apr;36(4):198-216. doi: 10.1016/j.it.2015.02.006. Review.

PMID:
25857662
32.

IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis.

Coffelt SB, Kersten K, Doornebal CW, Weiden J, Vrijland K, Hau CS, Verstegen NJM, Ciampricotti M, Hawinkels LJAC, Jonkers J, de Visser KE.

Nature. 2015 Jun 18;522(7556):345-348. doi: 10.1038/nature14282. Epub 2015 Mar 30.

33.

Morphine does not facilitate breast cancer progression in two preclinical mouse models for human invasive lobular and HER2⁺ breast cancer.

Doornebal CW, Vrijland K, Hau CS, Coffelt SB, Ciampricotti M, Jonkers J, de Visser KE, Hollmann MW.

Pain. 2015 Aug;156(8):1424-32. doi: 10.1097/j.pain.0000000000000136.

PMID:
25734987
34.

Determinants of reaching drug-free remission in patients with early rheumatoid or undifferentiated arthritis after one year of remission-steered treatment.

Wevers-de Boer KV, Heimans L, Visser K, Schouffoer AA, Molenaar ET, van Groenendael JH, Peeters AJ, Speyer I, Collée G, Huizinga TW, Allaart CF.

Rheumatology (Oxford). 2015 Aug;54(8):1380-4. doi: 10.1093/rheumatology/keu477. Epub 2015 Feb 15.

PMID:
25687553
35.

Improving psychosexual knowledge in adolescents with autism spectrum disorder: pilot of the tackling teenage training program.

Dekker LP, van der Vegt EJ, Visser K, Tick N, Boudesteijn F, Verhulst FC, Maras A, Greaves-Lord K.

J Autism Dev Disord. 2015 Jun;45(6):1532-40. doi: 10.1007/s10803-014-2301-9.

PMID:
25399394
36.

What do verbal fluency tasks measure? Predictors of verbal fluency performance in older adults.

Shao Z, Janse E, Visser K, Meyer AS.

Front Psychol. 2014 Jul 22;5:772. doi: 10.3389/fpsyg.2014.00772. eCollection 2014.

37.

Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy.

Ries CH, Cannarile MA, Hoves S, Benz J, Wartha K, Runza V, Rey-Giraud F, Pradel LP, Feuerhake F, Klaman I, Jones T, Jucknischke U, Scheiblich S, Kaluza K, Gorr IH, Walz A, Abiraj K, Cassier PA, Sica A, Gomez-Roca C, de Visser KE, Italiano A, Le Tourneau C, Delord JP, Levitsky H, Blay JY, Rüttinger D.

Cancer Cell. 2014 Jun 16;25(6):846-59. doi: 10.1016/j.ccr.2014.05.016. Epub 2014 Jun 2.

38.

Cancer: Inflammation lights the way to metastasis.

Coffelt SB, de Visser KE.

Nature. 2014 Mar 6;507(7490):48-9. doi: 10.1038/nature13062. Epub 2014 Feb 26. No abstract available.

PMID:
24572360
39.

Health-related quality of life and functional ability in patients with early arthritis during remission steered treatment: results of the IMPROVED study.

Heimans L, Wevers-de Boer KV, Koudijs KK, Visser K, Goekoop-Ruiterman YP, Harbers JB, Steup-Beekman GM, Lard LR, Grillet BA, Huizinga TW, Allaart CF.

Arthritis Res Ther. 2013 Oct 31;15(5):R173. doi: 10.1186/ar4361.

40.

Four-month metacarpal bone mineral density loss predicts radiological joint damage progression after 1 year in patients with early rheumatoid arthritis: exploratory analyses from the IMPROVED study.

Wevers-de Boer KV, Heimans L, Visser K, Kälvesten J, Goekoop RJ, van Oosterhout M, Harbers JB, Bijkerk C, Steup-Beekman M, de Buck MP, de Sonnaville PB, Huizinga TW, Allaart CF.

Ann Rheum Dis. 2015 Feb;74(2):341-6. doi: 10.1136/annrheumdis-2013-203749. Epub 2013 Nov 27.

PMID:
24285491
41.

Cyclopia extracts act as ERα antagonists and ERβ agonists, in vitro and in vivo.

Visser K, Mortimer M, Louw A.

PLoS One. 2013 Nov 4;8(11):e79223. doi: 10.1371/journal.pone.0079223. eCollection 2013. Erratum in: PLoS One. 2013;8(12). doi:10.1371/annotation/3306cc63-2aab-42b1-98c1-7507705fff98.

42.

Pharmacological inhibition of GSK-3 in a guinea pig model of LPS-induced pulmonary inflammation: I. Effects on lung remodeling and pathology.

Baarsma HA, Bos S, Meurs H, Visser KH, Smit M, Schols AM, Langen RC, Kerstjens HA, Gosens R.

Respir Res. 2013 Oct 23;14:113. doi: 10.1186/1465-9921-14-113.

43.

The use of the gonadotropin-releasing hormone analog deslorelin for short-term contraception in red pandas (Ailurus fulgens).

Koeppel KN, Barrows M, Visser K.

Theriogenology. 2014 Jan 15;81(2):220-4. doi: 10.1016/j.theriogenology.2013.09.003. Epub 2013 Oct 5.

PMID:
24100162
44.

The relationship between disease activity and depressive symptoms severity and optimism--results from the IMPROVED study.

Heimans L, Wevers-de Boer KV, Visser K, Ronday HK, Steup-Beekman GM, van Oosterhout M, Huizinga TW, Giltay EJ, van der Mast RC, Allaart CF.

Clin Rheumatol. 2013 Dec;32(12):1751-7. doi: 10.1007/s10067-013-2337-9. Epub 2013 Jul 24.

PMID:
23881438
45.

'Every picture tells a story': Interviews and diaries with children with cerebral palsy about adapted cycling.

Pickering D, Horrocks LM, Visser KS, Todd G.

J Paediatr Child Health. 2013 Dec;49(12):1040-4. doi: 10.1111/jpc.12289. Epub 2013 Jun 18.

PMID:
23781924
46.

A two-step treatment strategy trial in patients with early arthritis aimed at achieving remission: the IMPROVED study.

Heimans L, Wevers-de Boer KV, Visser K, Goekoop RJ, van Oosterhout M, Harbers JB, Bijkerk C, Speyer I, de Buck MP, de Sonnaville PB, Grillet BA, Huizinga TW, Allaart CF.

Ann Rheum Dis. 2014 Jul;73(7):1356-61. doi: 10.1136/annrheumdis-2013-203243. Epub 2013 May 28.

PMID:
23716067
47.

Phytoestrogenic potential of Cyclopia extracts and polyphenols.

Louw A, Joubert E, Visser K.

Planta Med. 2013 May;79(7):580-90. doi: 10.1055/s-0032-1328463. Epub 2013 Apr 22. Review.

48.

Personalized medicine: predicting responses to therapy in patients with RA.

van den Broek M, Visser K, Allaart CF, Huizinga TW.

Curr Opin Pharmacol. 2013 Jun;13(3):463-9. doi: 10.1016/j.coph.2013.03.006. Epub 2013 Apr 8. Review.

PMID:
23578763
49.

Five-year outcomes of probable rheumatoid arthritis treated with methotrexate or placebo during the first year (the PROMPT study).

van Aken J, Heimans L, Gillet-van Dongen H, Visser K, Ronday HK, Speyer I, Peeters AJ, Huizinga TW, Allaart CF.

Ann Rheum Dis. 2014 Feb;73(2):396-400. doi: 10.1136/annrheumdis-2012-202967. Epub 2013 Jan 19.

PMID:
23334213
50.

LIM kinase inhibition reduces breast cancer growth and invasiveness but systemic inhibition does not reduce metastasis in mice.

Li R, Doherty J, Antonipillai J, Chen S, Devlin M, Visser K, Baell J, Street I, Anderson RL, Bernard O.

Clin Exp Metastasis. 2013 Apr;30(4):483-95. doi: 10.1007/s10585-012-9553-6. Epub 2012 Dec 13.

PMID:
23239465

Supplemental Content

Loading ...
Support Center